Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey

To circumvent donor-to-donor heterogeneity which may lead to inconsistent results after treatment of acute graft-versus-host disease with mesenchymal stromal cells generated from single donors we developed a novel approach by generating these cells from pooled bone marrow mononuclear cells of 8 heal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kuçi, Zyrafete (VerfasserIn) , Jauch, Anna (VerfasserIn) , Janssen, Johannes W. G. (VerfasserIn) , Greil, Johann (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 2016
In: Haematologica
Year: 2016, Jahrgang: 101, Heft: 8, Pages: 985-994
ISSN:1592-8721
DOI:10.3324/haematol.2015.140368
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.3324/haematol.2015.140368
Verlag, Volltext: http://www.haematologica.org/content/101/8/985
Volltext
Verfasserangaben:Zyrafete Kuçi, Halvard Bönig, Hermann Kreyenberg, Milica Bunos, Anna Jauch, Johannes W. G. Janssen, Marijana Škifić, Kristina Michel, Ben Eising, Giovanna Lucchini, Shahrzad Bakhtiar, Johann Greil, Peter Lang, Oliver Basu, Irene von Luettichau, Ansgar Schulz, Karl-Walter Sykora, Andrea Jarisch, Jan Soerensen, Emilia Salzmann-Manrique, Erhard Seifried, Thomas Klingebiel, Peter Bader, Selim Kuçi

MARC

LEADER 00000caa a2200000 c 4500
001 1583652248
003 DE-627
005 20230427193404.0
007 cr uuu---uuuuu
008 181113s2016 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2015.140368  |2 doi 
035 |a (DE-627)1583652248 
035 |a (DE-576)513652248 
035 |a (DE-599)BSZ513652248 
035 |a (OCoLC)1341023445 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kuçi, Zyrafete  |e VerfasserIn  |0 (DE-588)117124276X  |0 (DE-627)1040442390  |0 (DE-576)51365304X  |4 aut 
245 1 0 |a Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease  |b a multicenter survey  |c Zyrafete Kuçi, Halvard Bönig, Hermann Kreyenberg, Milica Bunos, Anna Jauch, Johannes W. G. Janssen, Marijana Škifić, Kristina Michel, Ben Eising, Giovanna Lucchini, Shahrzad Bakhtiar, Johann Greil, Peter Lang, Oliver Basu, Irene von Luettichau, Ansgar Schulz, Karl-Walter Sykora, Andrea Jarisch, Jan Soerensen, Emilia Salzmann-Manrique, Erhard Seifried, Thomas Klingebiel, Peter Bader, Selim Kuçi 
264 1 |c August 2016 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Pre-published: May 12, 2016 
500 |a Gesehen am 13.11.2018 
520 |a To circumvent donor-to-donor heterogeneity which may lead to inconsistent results after treatment of acute graft-versus-host disease with mesenchymal stromal cells generated from single donors we developed a novel approach by generating these cells from pooled bone marrow mononuclear cells of 8 healthy “3rd-party” donors. Generated cells were frozen in 209 vials and designated as mesenchymal stromal cell bank. These vials served as a source for generation of clinical grade mesenchymal stromal cell end-products, which exhibited typical mesenchymal stromal cell phenotype, trilineage differentiation potential and at later passages expressed replicative senescence-related markers (p21 and p16). Genetic analysis demonstrated their genomic stability (normal karyotype and a diploid pattern). Importantly, clinical end-products exerted a significantly higher allosuppressive potential than the mean allosuppressive potential of mesenchymal stromal cells generated from the same donors individually. Administration of 81 mesenchymal stromal cell end-products to 26 patients with severe steroid-resistant acute graft-versus-host disease in 7 stem cell transplant centers who were refractory to many lines of treatment, induced a 77% overall response at the primary end point (day 28). Remarkably, although the cohort of patients was highly challenging (96% grade III/IV and only 4% grade II graft-versus-host disease), after treatment with mesenchymal stromal cell end-products the overall survival rate at two years follow up was 71±11% for the entire patient cohort, compared to 51.4±9.0% in graft-versus-host disease clinical studies, in which mesenchymal stromal cells were derived from single donors. Mesenchymal stromal cell end-products may, therefore, provide a novel therapeutic tool for the effective treatment of severe acute graft-versus-host disease. 
700 1 |a Jauch, Anna  |d 1959-  |e VerfasserIn  |0 (DE-588)1025525140  |0 (DE-627)722525362  |0 (DE-576)168357496  |4 aut 
700 1 |a Janssen, Johannes W. G.  |e VerfasserIn  |0 (DE-588)1025524683  |0 (DE-627)722522525  |0 (DE-576)182544656  |4 aut 
700 1 |a Greil, Johann  |e VerfasserIn  |0 (DE-588)1078331979  |0 (DE-627)838332455  |0 (DE-576)450711498  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Foundation, 2014  |g 101(2016), 8, Seite 985-994  |h Online-Ressource  |w (DE-627)814204899  |w (DE-600)2805244-4  |w (DE-576)424051125  |x 1592-8721  |7 nnas  |a Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease a multicenter survey 
773 1 8 |g volume:101  |g year:2016  |g number:8  |g pages:985-994  |g extent:10  |a Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease a multicenter survey 
856 4 0 |u http://dx.doi.org/10.3324/haematol.2015.140368  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.haematologica.org/content/101/8/985  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181113 
993 |a Article 
994 |a 2016 
998 |g 1078331979  |a Greil, Johann  |m 1078331979:Greil, Johann  |d 910000  |d 910500  |e 910000PG1078331979  |e 910500PG1078331979  |k 0/910000/  |k 1/910000/910500/  |p 12 
998 |g 1025524683  |a Janssen, Johannes W. G.  |m 1025524683:Janssen, Johannes W. G.  |d 910000  |d 911500  |e 910000PJ1025524683  |e 911500PJ1025524683  |k 0/910000/  |k 1/910000/911500/  |p 6 
998 |g 1025525140  |a Jauch, Anna  |m 1025525140:Jauch, Anna  |d 910000  |d 911500  |e 910000PJ1025525140  |e 911500PJ1025525140  |k 0/910000/  |k 1/910000/911500/  |p 5 
999 |a KXP-PPN1583652248  |e 303210548X 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Zyrafete Kuçi, Halvard Bönig, Hermann Kreyenberg, Milica Bunos, Anna Jauch, Johannes W. G. Janssen, Marijana Škifić, Kristina Michel, Ben Eising, Giovanna Lucchini, Shahrzad Bakhtiar, Johann Greil, Peter Lang, Oliver Basu, Irene von Luettichau, Ansgar Schulz, Karl-Walter Sykora, Andrea Jarisch, Jan Soerensen, Emilia Salzmann-Manrique, Erhard Seifried, Thomas Klingebiel, Peter Bader, Selim Kuçi"]},"note":["Pre-published: May 12, 2016","Gesehen am 13.11.2018"],"recId":"1583652248","person":[{"role":"aut","given":"Zyrafete","family":"Kuçi","display":"Kuçi, Zyrafete"},{"display":"Jauch, Anna","family":"Jauch","given":"Anna","role":"aut"},{"given":"Johannes W. G.","display":"Janssen, Johannes W. G.","family":"Janssen","role":"aut"},{"role":"aut","given":"Johann","display":"Greil, Johann","family":"Greil"}],"title":[{"title_sort":"Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease","subtitle":"a multicenter survey","title":"Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease"}],"physDesc":[{"extent":"10 S."}],"relHost":[{"part":{"issue":"8","year":"2016","extent":"10","pages":"985-994","text":"101(2016), 8, Seite 985-994","volume":"101"},"title":[{"subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title":"Haematologica","title_sort":"Haematologica"}],"titleAlt":[{"title":"journal of the European Hematology Association"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1592-8721"],"zdb":["2805244-4"],"eki":["814204899"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"origin":[{"publisher":"Ferrata Storti Foundation","dateIssuedKey":"2014","dateIssuedDisp":"2014-","publisherPlace":"Pavia"}],"pubHistory":["99.2014 -"],"note":["Gesehen am 27.05.2022"],"recId":"814204899","disp":"Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease a multicenter surveyHaematologica"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1583652248"],"doi":["10.3324/haematol.2015.140368"]},"language":["eng"],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"August 2016"}]} 
SRT |a KUCIZYRAFEMESENCHYMA2016